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In this issue of Structure, Tang and colleagues probe how the Flemish mutation in amyloid precursor protein
(APP) affects its conformation and cleavage by g-secretase. They provide molecular insight into how an
extracellular inhibitory element and cholesterol interactions affect the generation of Ab peptides.Various neurodegenerative diseases are
characterized by protein misfolding and
aggregation, which may be preceded or
accompanied by protease cleavage of
the affected proteins. Disease-related
mutations can thus affect not only the
aggregation process, but also this pivotal
cleavage event. In Alzheimer’s disease
(AD), cleavage of membrane-associated
APP by b- and g-secretases generates
aggregation-prone peptide fragments,
including Ab40 and Ab42 (Figure 1). The
study by Tang et al. (2014) in this issue
of Structure focuses on key structural
and genetic aspects of this crucial step.
The so-called Flemish mutation A21G
(A692G in full-length APP) leads to AD
accompanied by extensive Ab deposi-
tion. Although it may be tempting to attri-
bute this to a changed aggregation pro-
pensity of the mutant Ab peptide,
previous work indicates that it actually in-
creases the formation of Ab (e.g., De
Jonghe et al., 1998). Despite a closer
proximity to the a- and b-secretase
cleavage sites (Figure 2), it turns out that
this mutation actually increases g-secre-
tase activity by disrupting an extracel-Figure 1. Chain of Cleavage and Self-Assembly Events in
Alzheimer’s Disease
Full-length APP is cleaved by b- and g-secretases to give disease-causing Ab
peptides that are prone to self-assembly and aggregation. An extracellular
inhibitory ASID domain in APP (and its C-terminal fragment b-CTF) protects
against g-secretase cleavage. AD risk factors like cholesterol and the Flemish
mutation increase g-secretase activity, in part by disrupting the ASID.lular APP substrate inhibition
domain (ASID) (Tian et al.,
2010). Alas, the molecular un-
derpinnings of the inhibition
of g-secretase, and the effect
of the Flemish mutation re-
mained unclear.
Tang et al. (2014) now
confirm the inhibitory effect
of the extracellular ASID and
that the Flemish mutation dis-
rupts the g-secretase inhibi-
tion. Importantly, they go on
to probe structural features
of membrane-bound APP inboth wild-type and mutant proteins to
address the structural mechanisms in-
volved. To do so in the context of a lipid
bilayer environment, they leverage Fourier
transform infrared (FTIR) andmagic-angle
spinning (MAS) solid-state nuclear mag-
netic resonance (ssNMR) spectroscopies
complemented with mutational and iso-
topic labeling experiments. Thus, they
provide insight into the structural features
of the extracellular domain and, in partic-
ular, the inhibitory ASID. They find the
latter adopts a b sheet structure that is
disrupted by mutations, including the
A21G Flemish mutation. This secondary
structure change is accompanied by an
apparent extension of the transmem-
brane (TM) a helix, and an enhanced pro-
pensity of this helix to dimerize within the
membrane.
Dimerization of the APP TM domain has
been investigated by different structural
methods before, leading to divergent
models of the point of interaction between
the helices. Conflicting reports suggest
dimerization via different GxxxG or GxxxA
motifs (see, e.g., Chen et al., 2014 and
Song et al., 2013). Crucial MAS ssNMRStructure 22, March 4, 2014measurements by Tang et al. (2014) reveal
that, within their lipid bilayer samples,
the dimerization involves an intimate
interaction between Gly33 residues,
which is in contrast with detergent-based
studies that indicate a closer contact
involving Ala42.
Importantly, they also probe the effect
of cholesterol, which is a risk factor in
AD and appears to modulate the ability
of g-secretase to generate Ab. It is shown
that cholesterol enhances the TM do-
mains’ a helicity in a way that is similar
to (and synergistic with) the A21G muta-
tion. Cholesterol also modulates the pro-
pensity for the TM helices to dimerize,
reminiscent of earlier work (Barrett et al.,
2012; Song et al., 2013). As an aside,
and likely simply coincidence, the unex-
pected finding of mixed b/a secondary
structure in context of cholesterol binding
reminds us of our recent observations
(Hoop et al., 2012) when applying similar
methods to the presumed cholesterol-
binding ‘‘CRAC’’ motif of caveolin-1. It
seems that, like in APP, cholesterol-inter-
acting residues span an analogous b/a
transition, which might reflect a ‘‘CRAC-ª2014 Elselike’’ motif found in this exact
part of the protein (Abad
et al., 2009; Song et al., 2014).
The study by Tang et al.
(2014) helps to clarify a
number of ongoing debates
regarding the role of APP
mutations, TM dimerization,
and the effects of choles-
terol. These new insights are
specifically enabled by their
use of structural methods
that allow one to employ
lipid bilayers featuring various
phospholipid mixtures as wellvier Ltd All rights reserved 361
Figure 2. Structural Features
(A) Sequence of APP around the TM and inhibitory ASID domains (boxed), showing the Flemish mutation
A21G. a-, b-, and g-secretase cleavage sites are marked with blue arrows. The Ab-40/42 sequences are
shown in bright/dark red.
(B) Secondary structure elements for wild-type and the A21G mutant.
(C) Helical wheel plots of the segment marked in (B) showing the extended helix in the mutant (blue res-
idues) as well as the G33 dimerization site that is active in lipid bilayers. A black arrow indicates A42, which
is a key dimerization site in micellar environments. Although the TM domain is shown as a single a helix,
other studies suggest local distortions in both bilayers and micelles.
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Previewsas cholesterol. The combination of FTIR
and ssNMR is shown to be powerful and
highly complementary, with a key role for
isotopic labeling that benefits both
methods. The explicit comparison of
different lipid bilayers as well as micellar
membrane mimics makes it clear that
the latter abolish the ASID b sheet struc-
ture and reinforces previous observations362 Structure 22, March 4, 2014 ª2014 Elsevof sensitivity to the nature of the mem-
brane environment (Lu et al., 2011).
It appears that cholesterol and the
Flemish mutation both act through similar
mechanisms, involving modulation of
the ASID secondary structure, helicity of
the TM domain, and dimerization. This
raises ‘‘chicken and egg’’ type questions
regarding the interplay and sequence ofier Ltd All rights reservedthese structural effects. Moreover, how
do these structural features affect g-sec-
retase, both in terms of its propensity to
do the cleavage (the cause increased Ab
levels) and the location of cleavage
(changing the Ab40/42 ratios)? The cur-
rent work provides a starting point to
address these questions and highlights
the importance of the choice of mem-
brane mimics (Zhou and Cross, 2013)
when doing so.REFERENCES
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